SENSENIG BETHANY (Chief Financial Officer) sold 18.1% of their position (9.10K shares) of 9 METERS BIOPHARMA, INC. on the open market
Open‑market sale worth $11.0K — a significant reduction. Review remaining holdings and any 10b5‑1 plan disclosures.
S · 1 sale
Filed: 4/21/2023ACC: 0001551986-23-000026
Officer· Chief Financial Officer
Since Jan 2022
-9.10K
Net shares
Net seller
$11.0K
Total sold
1
Open market trades
0B · 1S
1
Total transactions
9.10K disposed
Non-Derivative Transactions1
Common stock
Direct
Shares
−9.10K
Price / share
$1.21
Trade value
$11.01K
% of position
18.1%
4/21/2023
50.18K→41.08K
Total
Net shares
−9.10K
Net value
-$11.01K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common stock Direct | 4/21/2023 | S · Sale | −9.10K | $1.21 | $11.01K | 18.1% | 50.18K | 41.08K |
| Total | −9.10K | -$11.01K | ||||||
Derivative Transactions0
No derivative transactions reported